Ocular Therapeutix, Inc.
OCUL · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $52.0M | $63.7M | −18.5% |
| Operating income | −$270M | −$172M | −57.2% |
| Net income | −$266M | −$194M | −37.4% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $12.9M | $14.5M | −11.0% |
| Operating income | −$97.9M | −$68.7M | −42.5% |
| Net income | −$94.8M | −$69.4M | −36.6% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Ocular Therapeutix's revenue in FY2025?
- $52.0M in FY2025 (Fiscal year ended Dec 31, 2025), −18.5% vs $63.7M a year earlier, per its 10-K filed Feb 2026.
- Was Ocular Therapeutix profitable in FY2025?
- No: net income was −$266M and operating income −$270M in FY2025.
- What was Ocular Therapeutix's revenue in Q3 2026?
- $12.9M (−11.0% vs a year earlier), per its Form 10-Q filed Nov 9, 2026.